| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2011 | US7888101 involving overexpression of alpha 1,2 mannosidase (MAN1C1) activity to improve protein production; improved glycoprotein production |
| 02/15/2011 | US7888100 Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein |
| 02/15/2011 | US7888097 Formulation for adenovirus storage |
| 02/15/2011 | US7888096 Liquid adenovirus formulations |
| 02/15/2011 | US7888093 Subtilase variants |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888090 reduced DNA interaction; localization of the expressed protein in eukaryotic cells that is no longer restricted to the nucleus; improved expression yield as soluble protein and improved stability in various hosts; oxidizing resistant;better in vitro solubility |
| 02/15/2011 | US7888089 Nucleotide sequences coding polypeptide for use in the treatment of cardivascular, restenosis, hypertension, atherosclerosis, heart defects, diabetes and neovascularization disorders; endothelial nitric oxide synthase (eNOS) |
| 02/15/2011 | US7888088 Superoxide dismutase (SOD) gene and a method of identifying and cloning thereof |
| 02/15/2011 | US7888087 Fusion protein of Fc-binding domain and calcium-binding photoprotein, gene encoding the same and use thereof |
| 02/15/2011 | US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 02/15/2011 | US7888072 Using bacteroides thetaiotaomicron gag lyase to specifically cleave heparin or heparan; for treating arthritic, inflammatory, angiogenic and eye disorders |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888070 in which the RSP sorting signal has been mutated such that the GH can be constitutively secreted by the nonregulated secretory pathway (NRSP) in a mammalian cell |
| 02/15/2011 | US7888069 for production of immune responses in individuals or detecting the presence of WNV specific or neutralizing antibodies |
| 02/15/2011 | US7888068 nucleic acid encoding a polypeptide capable of binding to IgE from subjects allergic to venom of a bee having a homology of more than 70% to the amino acid sequence of the honey bee allergen C |
| 02/15/2011 | US7888065 Comprises starch synthase for use in enhancing digestibility of food stuffs, paper processing, adhesives and textile processing |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7888047 PDEs as modifiers of the IGFR pathways and methods of use |
| 02/15/2011 | US7888038 modulating apoptosis-induced cell death comprising modulating the level of Bak Binding Protein (BBP) in a eukaryotic cell; drug screening |
| 02/15/2011 | US7888012 Antisense composition and method for treating muscle atrophy |
| 02/15/2011 | US7888010 for isolating, enriching, and/or labeling miRNA molecules and for preparing and using arrays or other detection techniques for miRNA analysis; biomarker for lung cancer; analyzing mir-205 expression |
| 02/15/2011 | US7888006 Obtain cells, lyse, separate cell components, resuspended in saline, subjet to enzymatic treatment, precipitate DNA, resuspend in low salt solution |
| 02/15/2011 | US7887866 clarified, native high acyl gellan; purified exopolysaccharide via heating and protease/hydrolase digestion; fermentation product of Sphingomonas; use as thickeners or gelling agent in food |
| 02/15/2011 | US7887821 from birch trees, weeds, herbs and grass via contacting with liquid extraction agent, separating liquids and solids, removing low molecular fractions via ultrafiltration, diafiltration, and/or dialysis |
| 02/15/2011 | US7887819 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887805 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | US7887793 for enhancing the proliferation and fusion of transplanted cells thereby to increase muscle mass or to prevent or treat muscle disease associated with a genetic defect |
| 02/15/2011 | US7887792 Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction |
| 02/15/2011 | US7887581 Methods of hemodialysis utilizing grafts coated with cells expressing human fibulin-5 |
| 02/15/2011 | CA2469647C Extraction and winterization of lipids from oilseed and microbial sources |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2439067C Lentiviral packaging constructs |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2429473C Membrane scaffold proteins |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2372632C Plant acyltransferases |
| 02/15/2011 | CA2357577C Phenol oxidizing enzymes |
| 02/15/2011 | CA2354046C New cancer treatments |
| 02/15/2011 | CA2326382C Sucrose phosphate synthase |
| 02/15/2011 | CA2321654C Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid |
| 02/15/2011 | CA2301826C Chimeric binding peptide library screening method |
| 02/15/2011 | CA2295332C Aib1, a novel steroid receptor co-activator |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/15/2011 | CA2266421C Genes coding for a protein having glycoside transfer activity |
| 02/15/2011 | CA2223616C Hypersensitive response induced resistance in plants |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/11/2011 | CA2675242A1 Single nucleotide polymorphisms (snps) in genes associated with inflammatory diseases |
| 02/10/2011 | WO2011017697A1 Compositions and methods for treating inflammatory disorders |
| 02/10/2011 | WO2011017696A2 Methods relating to aromatase inhibitor pharmacogenetics |
| 02/10/2011 | WO2011017691A2 Enhanced molecular detection of targeted intracellular mrna transcription using polynucleotide functionalized nanoparticles |
| 02/10/2011 | WO2011017596A2 Compositions and methods for identifying and detecting sites of translocation and dna fusion junctions |
| 02/10/2011 | WO2011017549A2 Filamentous fungi and methods for producing trichodiene from lignocellulosic feedstocks |
| 02/10/2011 | WO2011017516A2 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | WO2011017458A1 Design and implementation of novel and/or enhanced bacterial microcompartments for customizing metabolism |
| 02/10/2011 | WO2011017448A1 Use of histone deacetylase inhibitors for treatment of autoimmune diseases |
| 02/10/2011 | WO2011017422A2 Methods and compositions relating to controlled induction of plant senescence |
| 02/10/2011 | WO2011017414A2 Transgenic mouse lacking endogenous fviii and vwf - a model of hemophilia a |
| 02/10/2011 | WO2011017404A2 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 02/10/2011 | WO2011017382A2 Nanofibers and morphology shifting micelles |
| 02/10/2011 | WO2011017315A2 Methods and compositions for targeted gene modification |
| 02/10/2011 | WO2011017293A2 Engineering of zinc finger arrays by context-dependent assembly |
| 02/10/2011 | WO2011017251A1 Process and device for collecting nucleic acids of microorganisms from a particulate sample |
| 02/10/2011 | WO2011017107A2 Microbubble assisted viral delivery |
| 02/10/2011 | WO2011017013A2 Enterococcus and fecal bacteroides for rapid water quality assessment |
| 02/10/2011 | WO2011016841A2 Ripening promoter |
| 02/10/2011 | WO2011016714A1 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease |
| 02/10/2011 | WO2011016632A2 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor |
| 02/10/2011 | WO2011016588A1 Method of efficiently establishing induced pluripotent stem cells |
| 02/10/2011 | WO2011016568A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016567A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016565A1 Nucleic acid element for use in analysis, and analytical method, analytical reagent and analytical instrument using same |
| 02/10/2011 | WO2011016561A1 Dna capable of inducing osteoblast-specific expression, and nucleotide sequence for same |
| 02/10/2011 | WO2011016540A1 Novel ubiquitin ligase and use thereof |
| 02/10/2011 | WO2011016461A1 Tumor angiogenesis inhibitor |
| 02/10/2011 | WO2011016301A1 Process for production of l-lysine using bacterium belonging to genus vibrio |
| 02/10/2011 | WO2011016261A1 Method for establishment of pluripotent stem cell derived from differentiated cell |
| 02/10/2011 | WO2011016260A1 Novel glycosyltransferase, novel glycosyltransferase gene, and novel glycosyl donor compound |
| 02/10/2011 | WO2011016239A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016238A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016102A1 Mutant formate dehydrogenase, gene encoding same, and method for producing nadh |
| 02/10/2011 | WO2011016053A1 Dna loaded supported gold nanoparticles, process for the preparation and use thereof |
| 02/10/2011 | WO2011015924A2 Vectors and compounds for expression of recombinant trastuzumab |
| 02/10/2011 | WO2011015918A2 Vectors and compounds for expression of recombinant cetuximab |
| 02/10/2011 | WO2011015917A2 Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase) |
| 02/10/2011 | WO2011015916A2 Vectors and compounds for expression of recombinant infliximab |
| 02/10/2011 | WO2011015633A1 Method of producing a sweet protein |
| 02/10/2011 | WO2011015593A1 Methods and compounds for the diagnosis and treatment of cancer |
| 02/10/2011 | WO2011015591A1 Immunogenic composition comprising antigenic s. aureus proteins |
| 02/10/2011 | WO2011015121A1 Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |